CBT
Get informed when a big investor buys or sells
+ FollowUndervalued by 219.6% based on the discounted cash flow analysis.
| Market cap | $3.81 Billion |
|---|---|
| Enterprise Value | $4.85 Billion |
| Dividend Yield | $1.84 (2.50%) |
| Earnings per Share | $6.07 |
| Beta | 0.82 |
| Outstanding Shares | 51,600,000 |
| P/E Ratio | 20.44 |
|---|---|
| PEG | -21.73 |
| Price to Sales | 1.05 |
| Price to Book Ratio | 2.24 |
| Enterprise Value to Revenue | 1.34 |
| Enterprise Value to EBIT | 9.57 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 6.98% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.99%▼ 102.68% |
|---|---|
| Total Invested | $79.10M▼ 98.40% |
| Investors Holding | 68▼ 329.00% |
No data